Sign in with Google. Opens in new tab
ENTITY

Glaukos Corp (GKOS US)

8
Analysis
Health CareUnited States
Glaukos Corporation operates as an ophthalmic medical technology company. The Company develops, manufactures, and markets medical devices for the treatment of glaucoma. Glaukos offers micro-scale injectable therapies designed to address the complete range of glaucoma disease states and progression.
more
bullishGlaukos Corp
20 Jun 2025 20:00

Glaukos Corporation: An Insight Into The Latest Advancements in Product Adoption

Glaukos Corporation recently delivered its financial results for the first quarter of 2025, reporting a record consolidated net sales figure of...

Logo
378 Views
Share
bullishGlaukos Corp
08 Mar 2025 06:00

Glaukos Corporation: Can The iDose Market Expansion Fetch Significant Growth With iDose Platform?

Glaukos Corporation's financial results for the fourth quarter and full year 2024 reflect strong performance across multiple segments and...

Logo
288 Views
Share
bullishGlaukos Corp
16 Nov 2024 09:00

Glaukos Corporation: Advancement of iDose TR & Market Penetration As A Pivotal Growth Lever! - Major Drivers

Glaukos Corporation's third quarter 2024 financial results highlighted a period of notable growth driven by strategic product developments and an...

Logo
319 Views
Share
bullishGlaukos Corp
21 Oct 2024 19:00

Glaukos Corporation: These Are The 4 Reasons Why We Are Relatively Less Optimistic! - Major Drivers

Glaukos Corporation's second quarter earnings for 2024 revealed a 19% increase in consolidated net sales which amounted to $95.7 million,...

Logo
211 Views
Share
bullishGlaukos Corp
16 Jul 2024 06:00

Glaukos Corporation: Is The Enhanced Training & Scaling of Surgeon Adoption Enough To Warrant A Bullish Rating? - Major Drivers

Glaukom Corporation has reported a promising start to Q1 2024, underscoring strong sales and a forward-looking strategy driven by innovations in...

Logo
278 Views
Share
x